Articles by Stuart Kamin - Pharmaceutical Executive

ADVERTISEMENT

Articles by Stuart Kamin

Get a Grip on the Supply Chain

Sarbanes-Oxley revenue-recognition compliance is reducing perfectly competent execs to complete blubber. Here's help in figuring out when a sale is really a sale.
Apr 1, 2007

The Sarbanes-Oxley Act—or SOX, as it is dubbed (not always so affectionately)—requires companies to provide greater control and quality assurance across a vast spectrum of business processes. In practice, SOX plays out differently industry by industry and even company by company. But for pharma, one of the most pressing consequences is the need to improve the accuracy of revenue recognition.

ADVERTISEMENT

Click here